Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Proc Natl Acad Sci U S A. 1994 Aug 30; 91(18): 8532–8536.
PMCID: PMC44640
PMID: 8078917

A vaccine that prevents pregnancy in women.

Abstract

We report here results of clinical trials on a birth control vaccine, consisting of a heterospecies dimer of the beta subunit of human chorionic gonadotropin (hCG) associated noncovalently with the alpha subunit of ovine luteinizing hormone and conjugated to tetanus and diphtheria toxoids as carriers, that induces antibodies of high avidity (K(a) approximately 10(10) M-1) against hCG. Fertile women exposed to conception over 1224 cycles recorded only one pregnancy at antibody titers of > 50 ng/ml (hCG bioneutralization capacity). The antibody response declines with time; fertility was regained when titers fell to < 35 ng/ml. This study presents evidence of the feasibility of a vaccine for control of human fertility.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (914K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Primakoff P, Lathrop W, Woolman L, Cowan A, Myles D. Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20. Nature. 1988 Oct 6;335(6190):543–546. [PubMed] [Google Scholar]
  • Herr JC, Flickinger CJ, Homyk M, Klotz K, John E. Biochemical and morphological characterization of the intra-acrosomal antigen SP-10 from human sperm. Biol Reprod. 1990 Jan;42(1):181–193. [PubMed] [Google Scholar]
  • Sacco AG. Zona pellucida: current status as a candidate antigen for contraceptive vaccine development. Am J Reprod Immunol Microbiol. 1987 Dec;15(4):122–130. [PubMed] [Google Scholar]
  • Ladd A, Tsong YY, Prabhu G, Thau R. Effects of long-term immunization against LHRH and androgen treatment on gonadal function. J Reprod Immunol. 1989 May;15(2):85–101. [PubMed] [Google Scholar]
  • Moudgal NR, Ravindranath N, Murthy GS, Dighe RR, Aravindan GR, Martin F. Long-term contraceptive efficacy of vaccine of ovine follicle-stimulating hormone in male bonnet monkeys (Macaca radiata). J Reprod Fertil. 1992 Sep;96(1):91–102. [PubMed] [Google Scholar]
  • Talwar GP, Sharma NC, Dubey SK, Salahuddin M, Das C, Ramakrishnan S, Kumar S, Hingorani V. Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci U S A. 1976 Jan;73(1):218–222. [PMC free article] [PubMed] [Google Scholar]
  • Shahani SM, Kulkarni PP, Patel KL, Salahuddin M, Das C, Talwar GP. Clinical and immunological responses with Pr- beta-hCG-TT vaccine. Contraception. 1982 Apr;25(4):421–434. [PubMed] [Google Scholar]
  • Talwar GP, Singh O, Rao LV. An improved immunogen for anti-human chorionic gonadotropin vaccine eliciting antibodies reactive with a conformation native to the hormone without cross-reaction with human follicle stimulating hormone and human thyroid stimulating hormone. J Reprod Immunol. 1988 Dec;14(3):203–212. [PubMed] [Google Scholar]
  • Pal R, Singh O, Rao LV, Talwar GP. Bioneutralization capacity of the antibodies generated in women by the beta subunit of human chorionic gonadotropin (beta hCG) and beta hCG associated with the alpha subunit of ovine luteinizing hormone linked to carriers. Am J Reprod Immunol. 1990 Mar-Apr;22(3-4):124–126. [PubMed] [Google Scholar]
  • Gaur A, Arunan K, Singh O, Talwar GP. Bypass by an alternate 'carrier' of acquired unresponsiveness to hCG upon repeated immunization with tetanus-conjugated vaccine. Int Immunol. 1990;2(2):151–155. [PubMed] [Google Scholar]
  • Singh O, Rao LV, Gaur A, Sharma NC, Alam A, Talwar GP. Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin. Fertil Steril. 1989 Nov;52(5):739–744. [PubMed] [Google Scholar]
  • Kharat I, Nair NS, Dhall K, Sawhney H, Krishna U, Shahani SM, Banerjee A, Roy S, Kumar S, Hingorani V, et al. Analysis of menstrual records of women immunized with anti-hCG vaccines inducing antibodies partially cross-reactive with hLH. Contraception. 1990 Mar;41(3):293–299. [PubMed] [Google Scholar]
  • Talwar GP, Hingorani V, Kumar S, Roy S, Banerjee A, Shahani SM, Krishna U, Dhall K, Sawhney H, Sharma NC, et al. Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine. Contraception. 1990 Mar;41(3):301–316. [PubMed] [Google Scholar]
  • Nash H, Johansson ED, Talwar GP, Vasquez J, Segal S, Coutinho E, Luukkainen T, Sundaram K. Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril. 1980 Oct;34(4):328–335. [PubMed] [Google Scholar]
  • Thau RB, Wilson CB, Sundaram K, Phillips D, Donnelly T, Halmi NS, Bardin CW. Long-term immunization against the beta-subunit of ovine luteinizing hormone (oLH beta) has no adverse effects on pituitary function in rhesus monkeys. Am J Reprod Immunol Microbiol. 1987 Nov;15(3):92–98. [PubMed] [Google Scholar]
  • Thau RB, Sundaram K, Thornton YS, Seidman LS. Effects of immunization with the beta-subunit of ovine luteinizing hormone on corpus luteum function in the rhesus monkey. Fertil Steril. 1979 Feb;31(2):200–204. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences